UNCERTAINTY IN ECONOMICS : READINGS AND EXERCISES.

Por DIAMOND, PETER, ROTHSCHILD, MICHAEL
Publicado em S1978

A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts

Por Coles, Leeanne S., Diamond, Peter, Lambrusco, Lidia, Hunter, Julie, Burrows, Julie, Vadas, Mathew A., Goodall, Gregory J.
Publicado em 2002

Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo

Por Zinonos, Irene, Labrinidis, Agatha, Lee, Michelle, Liapis, Vasilios, Hay, Shelley, Ponomarev, Vladimir, Diamond, Peter, Findlay, David M, Zannettino, Andrew CW, Evdokiou, Andreas
Publicado no J Bone Miner Res (2011)

Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer

Por Zinonos, Irene, Labrinidis, Agatha, Lee, Michelle, Liapis, Vasilios, Hay, Shelley, Ponomarev, Vladimir, Diamond, Peter, Zannettino, Andrew C.W., Findlay, David M., Evdokiou, Andreas
Publicado no Mol Cancer Ther (2009)

Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells

Por Martin, Sally K., Diamond, Peter, Williams, Sharon A., To, Luen Bik, Peet, Daniel J., Fujii, Nobutaka, Gronthos, Stan, Harris, Adrian L., Zannettino, Andrew C.W.
Publicado em 2010

Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma

Por Labrinidis, Agatha, Diamond, Peter, Martin, Sally, Hay, Shelley, Liapis, Vasilios, Zinonos, Irene, Sims, Natalie A., Atkins, Gerald J., Vincent, Cristina, Ponomarev, Vladimir, Findlay, David M., Zannettino, Andrew C.W., Evdokiou, Andreas
Publicado no Clin Cancer Res (2009)